CM
EXAS

Crestline Management’s Exact Sciences EXAS Stock Holding History

Crestline Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,817
Closed -$271K – 221
2024
Q4 		$271K Sell
4,817
-1,765
-27% -$110K 0.01% 634
2024
Q3 		$448K Buy
+6,582
New +$371K 0.02% 386

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crestline Management's EXAS Position: Q1 2025 in Review

Crestline Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 4,817 shares — an estimated $271K sold.

Crestline Management first reported a position in EXAS in Q3 2024 and held it in 2 quarters. The position peaked at $448K in Q3 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Crestline Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 4,817 Exact Sciences shares in Q1 2025, an estimated $271K.
  • Crestline Management first reported a position in Exact Sciences in Q3 2024 and held it in 2 quarters.
  • Crestline Management's Exact Sciences position peaked at $448K in Q3 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.